© Provided by Hindustan Times The United States on October 29, 2021, authorised the Pfizer Covid-19 vaccine for children aged 5 to 11 after a committee of experts found its benefits outweighed risks. (File Photo / AFP)Pfizer Inc. and BioNTech SE’s Covid-19 vaccine was cleared by US regulators for children ages 5 to 11, a long-awaited pandemic milestone that opens a new phase of the immunization campaign. “Vaccinating younger children against Covid-19 will bring us closer to returning to a sense of normalcy,” acting FDA commissioner Janet Woodcock said in the statement. “The risk of myocarditis from the vaccine, even for boys, is lower than the risk of myocarditis from Covid itself,” she said. It may be a few months until authorities consider shots for children under age 5, Marks said.

Source: Hindustan Times October 30, 2021 16:32 UTC